Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2026-05-22 @ 1:33 AM
Study NCT ID:
NCT04649060
Status:
TERMINATED
Last Update Posted:
2023-06-08
First Post:
2020-11-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Melflufen (Melphalan Flufenamide) in Combination With Daratumumab in Relapsed-Refractory Multiple Myeloma
Sponsor:
Oncopeptides AB
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
OP-108
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None